2. Siilin H., Lundgren E., Mallmin H., et al. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg. 2011;35(6):1266–72. doi: 10.1007/s00268-011-1062-2.

3. Clarke B.L. Asymptomatic Primary Hyperparathyroidism. Front Horm Res. 2019;51:13–22. doi: 10.1159/000491035.

4. Cusano N.E., Cetani F. Normocalcemic primary hyperparathyroidism. Arch Endocrinol Metab. 2022;66(5):666–77. doi: 10.20945/2359-3997000000556.

5. Мокрышева Н.Г., Еремкина А.К., Мирная С.С. и др. Клинические рекомендации по первичному гиперпаратиреозу, краткая версия. Проблемы эндокринологии. 2021;67(4):94–124.

6. Пояркова В.О., Рунова Г.Е., Фадеев В.В. Нейрокогнитивные аспекты гиперпаратиреоза. Ожирение и метаболизм. 2019;16(1):7–11.

7. Chandran M., Yeh L.T.L., de Jong M.C., et al. Cognitive deficits in primary hyperparathyroidism - what we know and what we do not know: A narrative review. Rev Endocr Metab Disord. 2022;23(5):1079–87. doi: 10.1007/s11154-022-09750-9.

8. Мокрышева Н.Г., Крупинова Ю.А., Бибик Е.Е., Мельниченко Г.А. Когнитивные нарушения при первичном гиперпаратиреозе. Неврология, нейропсихиатрия, психосоматика. 2019;11(1):103–8.

9. Babinska D., Barczynski M., Stefaniak T., et al. Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism. Langenbecks Arch Surg. 2012;397(5):825–31. doi: 10.1007/s00423-011-0885-5.

10. Pokhrel B., Leslie S.W., Levine S.N. Primary Hyperparathyroidism. 2024 Mar 1. In: StatPearls

11. Crepeau P., Fedorova T., Morris-Wiseman L.F., Mathur A. Secondary Hyperparathyroidism and Cognitive Decline. Curr Transplant Rep. 2023;10(2):60–8. doi: 10.1007/s40472-023-00394-5.

12. Schram M.T., Trompet S., Kamper A.M., et al. Serum calcium and cognitive function in old age. J Am Geriatr Soc. 2007;55(11):1786–92. doi: 10.1111/j.1532-5415.2007.01418.x.

13. Ann McDonald C., Bruce D.G., Smith D.J. Primary hyperparathyroidism in an elderly woman: surgical reversibility of profound mental state problems due to mild hypercalcaemia. Int J Geriatr Psych. 2002;17(7):601–3. doi: 10.1002/gps.648.

14. Joborn C., Hetta J., Niklasson F., et al. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinol. 1991;16(4):311–22. doi: 10.1016/0306-4530(91)90017-n.

15. Mjåland O., Normann E., Halvorsen E., et al. Regional cerebral blood flow in patients with primary hyperparathyroidism before and after successful parathyroidectomy. Br J Surg. 2003;90(6):732–7. doi: 10.1002/bjs.4131.

16. Szalat A., Tamir N., Mazeh H., Newman J.P. Successful parathyroidectomy improves cognition in patients with primary hyperparathyroidism: A prospective study in a tertiary medical center and comprehensive review of the literature. Front Endocrinol (Lausanne). 2022;13:1095189. doi: 10.3389/fendo.2022.1095189.

17. Mittendorf E.A., Wefel J.S., Meyers C.A., et al. Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract. 2007;13(4):338–44. doi: 10.4158/EP.13.4.338.

18. Rasche R.V., Schuster F., Meurer N., et al. Influence of Parathyroidectomy on Sleep Quality in Primary Hyperparathyroidism. Adv Exp Med Biol. 2021;1335:121–7. doi: 10.1007/5584_2021_628.

19. Wang Y., Xin Y., Zhao T., et al. PTH levels, sleep quality, and cognitive function in primary hyperparathyroidism. Endocrine. 2023;81(2):379–87. doi: 10.1007/s12020-023-03410-x.

20. Kreimeyer K., Foster M., Pandey A., et al. Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review. J Biomed Inform. 2017;73:14–29. doi: 10.1016/j.jbi.2017.07.012.

21. Iglesias P., Arias J., Lopez G., et al. Primary Hyperparathyroidism and Cardiovascular Disease: An Association Study Using Clinical Natural Language Processing Systems and Big Data Analytics. J Clin Med. 2023; 12(21):6718. https://doi.org/10.3390/jcm12216718.

22. Axelsson K.F., Wallander M., Johansson H., et al. Analysis of Comorbidities, Clinical Outcomes, and Parathyroidectomy in Adults With Primary Hyperparathyroidism. JAMA Netw Open. 2022;5(6):e2215396. doi: 10.1001/jamanetworkopen.2022.15396.

23. Modica R., Liccardi A., Minotta R., et al. Parathyroid diseases and metabolic syndrome. J Endocrinol Invest. 2023;46(6):1065–77. doi: 10.1007/s40618-023-02018-2.

24. Koufakis T., Antonopoulou V., Grammatiki M., et al. The Relationship between Primary Hyperparathyroidism and Thrombotic Events: Report of Three Cases and a Review of Potential Mechanisms. Int J Hematol Oncol Stem Cell Res. 2018;12(3):175–80.

25. Mendoza-Zubieta V., Gonzalez-Villasenor G.A., Vargas-Ortega G., et al. High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT). BMC Endocr Disord. 2015;15:16. doi: 10.1186/s12902-015-0014-5.

26. Civitelli R. Parathyroid hormone control of intracellular calcium. J Endocrinol Invest. 1992;15(9 Suppl. 6):35–41.

27. Barnett M.J. Association Between Primary Hyperparathyroidism and Secondary Diabetes Mellitus: Findings From a Scoping Review. Cureus. 2023;15(6):e40743. doi: 10.7759/cureus.40743.

28. Sun Q., Zhang T., Chen P., et al. Glucose metabolic disorder in primary hyperparathyroidism: a systematic review and meta-analysis. Int J Clin Exp Med. 2019;12(9):11964–73. https://ijcem.com/files/ijcem0093873.pdf.

29. Мокрышева Н.Г. Первичный гиперпаратиреоз. Эпидемиология, клиника, современные принципы диагностики и лечения. Дисс. докт. мед. наук. М., 2011. [Mokrysheva N.G. Primary hyperparathyroidism. Epidemiology, clinic, modern principles of diagnosis and treatment. Diss. Doct. Of Med. Sciences. M., 2011. (In Russ.).

30. Горбачева А.М., Бибик Е.Е., Добрева Е.А. и др. Структура метаболических нарушений и сердечно-сосудистых заболеваний у пациентов с первичным гиперпаратиреозом: одноцентровое ретроспективное обсервационное исследование. Профилактическая медицина. 2022;25(8):54–66.

31. Nikooei Noghani S., Milani N., Afkhamizadeh M., et al. Assessment of insulin resistance in patients with primary hyperparathyroidism before and after Parathyroidectomy. Endocrinol Diab Metab. 2021;4(4):e00294. doi: 10.1002/edm2.294.

32. Christensen M.H., Fenne I.S., Nordbo Y., et al. Novel inflammatory biomarkers in primary hyperparathyroidism. Eur J Endocrinol. 2015;173(1):9–17. doi: 10.1530/EJE-14-1038.

33. Gruson D. PTH and cardiovascular risk. Ann Endocrinol (Paris). 2021;82(3-4):149–50. doi: 10.1016/j.ando.2020.02.005.

34. Бибик Е.Е., Горбачева А.М., Добрева Е.А. и др. Изменения метаболических параметров у пациентов с первичным гиперпаратиреозом различных возрастных групп. Ожирение и метаболизм. 2022;19(3):242–51.

35. Godang K., Lundstam K., Mollerup C., et al. The SIPH Study Group. The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism. Endocr Connect. 2018;7(8):941–8. doi: 10.1530/EC-18-0259.

36. Kalla A., Krishnamoorthy P., Gopalakrishnan A., et al. Primary hyperparathyroidism predicts hypertension: Results from the National Inpatient Sample. Int J Cardiol. 2017;227:335–7. doi: 10.1016/j.ijcard.2016.11.080.

37. Halapas A., Diamanti-Kandarakis E., Kremastinos D., Koutsilieris M. The PTHrP/PTH.1-R bioregulation system in cardiac hypertrophy: possible therapeutic implications. In Vivo. 2006;20(6B):837–44.

38. Grant F.D., Mandel S.J., Brown E.M., et al. Interrelationships between the renin-angiotensin-aldosterone and calcium homeostatic systems. J Clin Endocrinol Metab. 1992;75(4):988–92. doi: 10.1210/jcem.75.4.1400892.

39. Watanabe S, Fukumoto S, Chang H et al. Association between activating mutations of calcium-sensing receptor and Bartter’s syndrome. Lancet. 2002 Aug 31;360(9334):692-4. doi: 10.1016/S0140-6736(02)09842-2.

40. Verheyen N., Fahrleitner-Pammer A., Pieske B., et al. Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial. J Hypertens. 2016;34(9):1778–86. doi: 10.1097/HJH.0000000000001004.

41. Storvall S., Ryhanen E.M., Heiskanen I., et al. Surgery Significantly Improves Neurocognition, Sleep, and Blood Pressure in Primary Hyperparathyroidism: A 3-Year Prospective Follow-Up Study. Horm Metab Res. 2017;49(10):772–7. doi: 10.1055/s-0043-118347.

42. Graff-Baker A.N., Bridges L.T., Chen Q., et al. Parathyroidectomy for Patients With Primary Hyperparathyroidism and Associations With Hypertension. JAMA Surg. 2020;155(1):32–9. doi: 10.1001/jamasurg.2019.3950.

43. Ejlsmark-Svensson H., Rolighed L., Rejnmark L. Effect of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism: A Randomized Clinical Trial. J Clin Endocrinol Metab. 2019;104(8):3223–32. doi: 10.1210/jc.2018-02456.

44. Курзанов А.Н., Быков И.М., Ледванов М.Ю. Паратиреоидный гормон-родственный белок – современные представления о структуре, биохимических характеристиках и физиологической роли в организме. Современные проблемы науки и образования. 2016:6. URL: https://science-education.ru/ru/article/view?id=25543 (дата обращения: 15.10.2024).

45. Brown S.J., Ruppe M.D., Tabatabai L.S. The Parathyroid Gland and Heart Disease. Methodist Debakey Cardiovasc J. 2017;13(2):49–54. doi: 10.14797/mdcj-13-2-49.

46. McMahon D.J., Carrelli A., Palmeri N., et al. Effect of Parathyroidectomy Upon Left Ventricular Mass in Primary Hyperparathyroidism: A Meta-Analysis. J Clin Endocrinol Metab. 2015;100(12):4399–407. doi: 10.1210/jc.2015-3202.

47. Best C.A.E., Krishnan R., Malvankar-Mehta M.S., MacNeil S.D. Echocardiogram changes following parathyroidectomy for primary hyperparathyroidism: A systematic review and meta-analysis. Medicine (Baltimore). 2017;96(43):e7255. doi: 10.1097/MD.0000000000007255.

48. Shimoyama M., Ogino K., Furuse Y., et al. Signaling pathway and chronotropic action of parathyroid hormone in isolated perfused rat heart. J. Cardiovasc. Pharmacol. 2001;38(4):491–9. doi: 10.1097/00005344-200110000-00001.

49. Colak S., Aydogan B.I., Gokcay Canpolat A., et al. Is primary hyperparathyroidism a cause of endothelial dysfunction? Clin Endocrinol (Oxf). 2017;87(5):459–65. doi: 10.1111/cen.13418.

50. Pepe J., Magna A., Sonato C., et al. Twenty-four hour Holter ECG in normocalcemic and hypercalcemic patients with hyperparathyroidism. J Endocrinol Invest. 2024;47(6):1499–504. doi: 10.1007/s40618-023-02264-4.

51. Koubaity O., Mandry D., Nguyen-Thi P.L., et al. Coronary artery disease is more severe in patients with primary hyperparathyroidism. Surgery. 2020;167(1):149–54. doi: 10.1016/j.surg.2019.05.094.

52. Seib C.D., Meng T., Cisco R.M., et al. Adverse Cardiovascular Outcomes Among Older Adults With Primary Hyperparathyroidism Treated With Parathyroidectomy Versus Nonoperative Management. Ann Surg. 2023;278:e302–8. doi: 10.1097/SLA.0000000000005691.

53. Aresta C., Passeri E., Corbetta S. Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity. Int J Endocrinol. 2019;30:7617254. doi: 10.1155/2019/7617254.

54. Кудашкина Е.Ю., Гавриленко Е.Г., Якушев А.А. и др. Первичный гиперпаратиреоз с преимущественным поражением желудочно-кишечного тракта. Архивъ внутренней медицины. 2021;11(1):51–9.

55. Sharma S., Longo W.E., Baniadam B., Vernava A.M. Colorectal manifestations of endocrine disease. Dis Colon Rectum. 1995;38(3):318–23. doi: 10.1007/BF02055611.

56. Abboud B., Daher R., Boujaoude J. Digestive manifestations of parathyroid disorders. World J Gastroenterol. 2011;17(36):4063–6. doi: 10.3748/wjg.v17.i36.4063.

57. Баранова И.А., Баранов А.В. Патология желудочно-кишечного тракта у пациентов с первичным гиперпаратиреозом. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(5):24–30.

58. Heidarpour M., Karami M., Hedayat P., Aminorroaya A. Two rare manifestations of primary hyperparathyroidism: paralysis and peptic ulcer bleeding. Endocrinol Diab Metab Case Rep. 2017;10:17–0059. doi: 10.1530/EDM-17-0059.

59. Зубков А.В., Краюшкин А.И., Жигануров И.Р., Рыбак Е.Н. Острый панкреатит вследствие аденомы околощитовидной железы. Вопросы реконструктивной и пластической хирургии. 2019;22(3):41–5.

60. Bhadada S.K., Udawat H.P., Bhansali A., et al. Chronic pancreatitis in primary hyperparathyroidism: comparison with alcoholic and idiopathic chronic pancreatitis. J Gastroenterol Hepatol. 2008;23(6):959–64. doi: 10.1111/j.1440-1746.2007.05050.x.

61. Демидова Т.Ю., Кишкович Ю.С. Манифестная форма первичного гиперпаратиреоза. Клиническое наблюдение. Русский медицинский журнал. 2019;27(12):29–32.

62. Nilsson I.L., Zedenius J., Yin L., Ekbom A. The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy. Endocr Relat Cancer. 2007;14(1):135–40. doi: 10.1677/erc.1.01261.